To gain insights of potential mechanism underlying the pro-growth effect of TIMP-1 in prostate cancer, we performed immunohistochemistry (IHC) analyses of the tumor sections derived from these in vivo experiments and observed that the tumor sections derived from the prostate cancer cells with increased expression of TIMP-1 display increased amount of CAFs (Figure 3-top and middle panels). Here, TIMP1 is linked to prostate cancer.